Alignment Healthcare Files 8-K for Regulation FD Disclosure

Ticker: ALHC · Form: 8-K · Filed: Jan 8, 2024 · CIK: 1832466

Alignment Healthcare, Inc. 8-K Filing Summary
FieldDetail
CompanyAlignment Healthcare, Inc. (ALHC)
Form Type8-K
Filed DateJan 8, 2024
Risk Levellow
Pages5
Reading Time7 min
Key Dollar Amounts$0.001, $1,780, $1,800, $206, $214
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulation-fd, disclosure, corporate-governance

TL;DR

**ALHC just dropped an 8-K, likely sharing new info under fair disclosure rules.**

AI Summary

Alignment Healthcare, Inc. filed an 8-K on January 8, 2024, to report a Regulation FD Disclosure and to file financial statements and exhibits. This filing indicates that the company is providing information to the public that was previously non-public, ensuring fair disclosure to all investors. For shareholders, this means new, potentially material information about Alignment Healthcare is now available, which could influence their investment decisions.

Why It Matters

This filing ensures all investors receive important company information simultaneously, preventing unfair advantages and promoting transparency.

Risk Assessment

Risk Level: low — This 8-K is a standard disclosure filing and does not inherently indicate new risks, but rather ensures transparency.

Analyst Insight

Investors should review any accompanying exhibits or subsequent announcements from Alignment Healthcare, Inc. to understand the specific information disclosed under Regulation FD, as this could contain material information impacting the stock.

Key Numbers

  • 2024-01-08 — Date of Report (The date the earliest event reported in the 8-K occurred.)
  • 001-40295 — Commission File Number (Unique identifier for Alignment Healthcare, Inc. with the SEC.)
  • 46-5596242 — IRS Employer Identification No. (Tax identification number for Alignment Healthcare, Inc.)
  • $0.001 — par value per share (The nominal value of Alignment Healthcare, Inc. common stock.)

Key Players & Entities

  • Alignment Healthcare, Inc. (company) — the registrant filing the 8-K
  • Delaware (company) — state of incorporation for Alignment Healthcare, Inc.
  • The NASDAQ Stock Market LLC (company) — exchange where Alignment Healthcare, Inc. common stock is registered
  • 001-40295 (dollar_amount) — Commission File Number
  • 46-5596242 (dollar_amount) — IRS Employer Identification No.
  • 844-310-2247 (dollar_amount) — Registrant's Telephone Number

Forward-Looking Statements

  • Alignment Healthcare will likely hold an investor call or release further details related to the Regulation FD disclosure soon. (Alignment Healthcare, Inc.) — medium confidence, target: 2024-01-31

FAQ

What is the primary purpose of this 8-K filing by Alignment Healthcare, Inc.?

The primary purpose of this 8-K filing by Alignment Healthcare, Inc. is to report a Regulation FD Disclosure and to file financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Regulation FD Disclosure' and 'ITEM INFORMATION: Financial Statements and Exhibits' sections.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on January 8, 2024, as stated in the 'Date of Report (Date of earliest event reported): January 8, 2024' section.

Where is Alignment Healthcare, Inc. incorporated and what is its business address?

Alignment Healthcare, Inc. is incorporated in Delaware. Its principal executive offices are located at 1100 W Town and Country Road, Suite 1600, Orange, California, 92868.

On which stock exchange is Alignment Healthcare, Inc.'s common stock registered?

Alignment Healthcare, Inc.'s Common Stock, with a par value of $0.001 per share, is registered on The NASDAQ Stock Market LLC, as listed under 'Name of each exchange on which registered'.

What is the Central Index Key (CIK) for Alignment Healthcare, Inc.?

The Central Index Key (CIK) for Alignment Healthcare, Inc. is 0001832466, as found in the 'FILER: COMPANY DATA: CENTRAL INDEX KEY' section.

Filing Stats: 1,627 words · 7 min read · ~5 pages · Grade level 15.5 · Accepted 2024-01-08 08:01:25

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share ALHC The NASDAQ Stock Mar
  • $1,780 — : $ Millions Low High Revenue $1,780 $1,800 Adjusted Gross Profit 1 $2
  • $1,800 — lions Low High Revenue $1,780 $1,800 Adjusted Gross Profit 1 $206 $214
  • $206 — 80 $1,800 Adjusted Gross Profit 1 $206 $214 Adjusted EBITDA 2 ($34) ($
  • $214 — ,800 Adjusted Gross Profit 1 $206 $214 Adjusted EBITDA 2 ($34) ($26) 1
  • $34 — 1 $206 $214 Adjusted EBITDA 2 ($34) ($26) 1. Adjusted gross profit is
  • $26 — 6 $214 Adjusted EBITDA 2 ($34) ($26) 1. Adjusted gross profit is a non-GA

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Members of Alignment Healthcare, Inc.’s (the “ Company ”) senior management team are scheduled to meet with investors and analysts at an industry conference and various other meetings on January 8-11, 2024. During the conference and meetings, the Company intends to address aspects of its prospects and performance as described below. The date and time of presentations to investors are available via the Investor Relations calendar of events and presentations on the Company's website at www.alignmenthealth.com. The Company’s presentation during the industry conference on January 10, 2024 is expected to be webcast and a replay will be available on the Company's Investor Relations website. Update on 2024 Membership Outlook, 2024 Profitability Expectations and Full-Year 2023 Guidance The Company has completed the Annual Enrollment Period ( AEP ) for 2024 and currently estimates that it will have approximately 155,500 members enrolled in its HMO and PPO contracts ( Health Plan Members ) as of January 1, 2024. This figure represents Health Plan Member growth of approximately 44% year over year when compared with the Company's Health Plan Membership as of January 1, 2023. Additionally, the Company expects to have 162,000 to 164,000 members as of December 31, 2024, representing approximately 38% growth relative to the midpoint of the Company’s latest Health Plan Membership guidance for year-end 2023 provided on November 2, 2023. Additionally, the Company expects the midpoint of its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) guidance to be breakeven in 2024. The Company expects to provide its full 2024 guidance on its fourth quarter 2023 earnings call. Lastly, the Company is reaffirming its revenue, adjusted gross profit and adjusted EBITDA financial guidance ranges for the fiscal year ended December 31, 2023, and additionally expects adjusted EBITDA results t

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Alignment Healthcare, Inc. Investor Presentation dated January 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ALIGNMENT HEALTHCARE, INC. Date: January 8, 2024 By: /s/ Thomas Freeman Thomas Freeman Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.